High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis

scientific article published on June 2005

High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10620-005-2721-7
P698PubMed publication ID15986871

P50authorCengiz BolukbasQ117814155
Fusun F BolukbasQ117814161
P2093author name stringMehmet Aslan
Ilyas Ozardali
Fadile Zeyrek
Halil I Bahcecioglu
P2860cites workRegulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cellsQ70767689
Chlamydia pneumoniaeQ72190879
Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertensionQ72680461
Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytesQ73420947
Liver fibrosis in overweight patientsQ28145482
Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertensionQ28182623
Nonalcoholic fatty liver disease: a feature of the metabolic syndromeQ28208772
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed diseaseQ28282463
The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitisQ28345942
Steatohepatitis: a tale of two "hits"?Q29547771
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesionsQ33731663
Epidemiology of Chlamydia pneumoniae in atherosclerosisQ33762140
Mitochondria in steatohepatitisQ34215174
Obesity: assessment and management in primary care.Q34288595
Update on nonalcoholic fatty liver diseaseQ34548921
Review article: Non-alcoholic fatty liver diseaseQ35106643
Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional studyQ36244426
Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae.Q37866763
Chlamydia pneumoniae DNA is more frequent in advanced than in mild atherosclerosis lesionsQ37867438
Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in SingaporeQ37870815
Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndromeQ37870838
A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved?Q37871742
Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosisQ37877539
Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosisQ37881850
Pathogenesis of chlamydial infectionsQ37899066
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarctionQ37899465
Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial functionQ39782391
Structure and function of immunoglobulin AQ39921222
Antibiotic therapy in coronary heart disease--where do we currently stand?Q43424415
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 yearsQ45787554
P433issue6
P921main subjectsteatohepatitisQ2335423
Chlamydia pneumoniaeQ62869737
P304page(s)1141-1145
P577publication date2005-06-01
P1433published inDigestive Diseases and SciencesQ15716711
P1476titleHigh rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis
P478volume50

Reverse relations

Q37274899Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient micecites workP2860

Search more.